MERS-CoV E ORF Mammalian Expression Plasmid [N-HA] (CAT#: VPLd-Wyb051)

• Product Overview
• MERS-CoV (NCoV / Novel coronavirus), Mammalian expression plasmid, Envelope ORF Protein [N-HA].

• Promoter
• Enhanced CMV promoter

• Tag
• N-HA

• Vector
• pCMV3-SP-N-HA

• Target
• MERS-CoV

• NCBI Reference
• JX869059.2

• Length
• 249 bp

• Bacterial Resistance
• Kanamycin

• Cell Resistance
• Hygromycin

• Product Form
• Lyophilized

• Applications
• Used for stable or transient mammalian expression.

• Storage
• Ambient temperature

• Introduction
• The MERS (Middle East Respiratory Syndrome) virus is a new type of coronavirus, and most MERS virus infections occur in Saudi Arabia. MERS-CoV was first discovered in Saudi Arabia in September 2012. It is similar to the SARS virus in its clinical symptoms. It was also named SARS-like virus in the early days. It is the sixth known human coronavirus. MERS-CoV is often confused with SARS, but in fact both viruses belong to the coronavirus, but they are genetically distinct and they use different receptors when infecting humans.

• Alternative Names
• Middle East Respiratory Syndrome Virus; MERS-CoV; Nidovirales; Coronaviridae; Coronavirus; MERS coronavirus